rs61995933
Positions:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The ENST00000268638.10(IRF8):c.894C>T(p.Phe298=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00708 in 1,612,538 control chromosomes in the GnomAD database, including 49 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0053 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0073 ( 47 hom. )
Consequence
IRF8
ENST00000268638.10 synonymous
ENST00000268638.10 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.45
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 16-85918709-C-T is Benign according to our data. Variant chr16-85918709-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 542149.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.45 with no splicing effect.
BS2
High AC in GnomAd4 at 811 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF8 | NM_002163.4 | c.894C>T | p.Phe298= | synonymous_variant | 7/9 | ENST00000268638.10 | NP_002154.1 | |
IRF8 | NM_001363907.1 | c.924C>T | p.Phe308= | synonymous_variant | 7/9 | NP_001350836.1 | ||
IRF8 | NM_001363908.1 | c.282C>T | p.Phe94= | synonymous_variant | 5/7 | NP_001350837.1 | ||
IRF8 | XM_047434052.1 | c.924C>T | p.Phe308= | synonymous_variant | 8/10 | XP_047290008.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF8 | ENST00000268638.10 | c.894C>T | p.Phe298= | synonymous_variant | 7/9 | 1 | NM_002163.4 | ENSP00000268638 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00533 AC: 811AN: 152286Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
811
AN:
152286
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00528 AC: 1312AN: 248584Hom.: 5 AF XY: 0.00531 AC XY: 716AN XY: 134916
GnomAD3 exomes
AF:
AC:
1312
AN:
248584
Hom.:
AF XY:
AC XY:
716
AN XY:
134916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00726 AC: 10603AN: 1460134Hom.: 47 Cov.: 31 AF XY: 0.00714 AC XY: 5188AN XY: 726478
GnomAD4 exome
AF:
AC:
10603
AN:
1460134
Hom.:
Cov.:
31
AF XY:
AC XY:
5188
AN XY:
726478
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00532 AC: 811AN: 152404Hom.: 2 Cov.: 33 AF XY: 0.00490 AC XY: 365AN XY: 74532
GnomAD4 genome
AF:
AC:
811
AN:
152404
Hom.:
Cov.:
33
AF XY:
AC XY:
365
AN XY:
74532
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | IRF8: BP4, BP7, BS2 - |
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;C4016741:Immunodeficiency 32B Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
IRF8-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 06, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at